Navigation Links
Isis Announces Appointment of B. Lynne Parshall as Chief Operating Officer
Date:12/14/2007

CARLSBAD, Calif., Dec. 14 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) today announced that its Board of Directors has promoted B. Lynne Parshall, J.D. to Chief Operating Officer, effective immediately. Ms. Parshall retains her position as Chief Financial Officer, and is a Director of the Company.

"This promotion is well-deserved, and appropriately reflects the scope of Lynne's responsibilities at Isis," commented Stanley Crooke, M.D., Ph.D., Isis' President and CEO. "Lynne has been an integral part of Isis' management team for many years, and has been performing COO functions now for quite some time. This promotion recognizes her outstanding contributions and the nature of her current role with the Company."

Ms. Parshall joined Isis in November 1991, and she has served as Director since 2000, Executive Vice President since 1995, Chief Financial Officer since 1994 and Secretary since 1991. Ms. Parshall is currently responsible for overseeing the operations of finance, legal, patents, manufacturing and business development and is also very involved in the Company's corporate communications activities. Previously, Ms. Parshall was a Partner with the firm of Cooley Godward LLP, now Cooley Godward Kronish LLP, where she represented several health care companies in a general practice specializing in corporate partnering and other technology-based transactions. Ms. Parshall received her J.D. at Stanford Law School, Stanford, California and her B.A. from Harvard University, Cambridge, Massachusetts. Ms. Parshall is on the board of CardioDynamics International Corporation and is a Trustee of The Bishop School in La Jolla. Ms. Parshall is also a member of the Licensing Executives Society and a member of the Ame
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...eration of ultrasmall transistors and more powerfu...conducting nanowires are closer to reality after a...rsity and the University of California at Los Ange...e nanowires with layers of different materials tha...s a critical requirement for making efficient tran...
(Date:11/25/2009)...BOCA RATON, Fla., Nov. 25 For many...for BodyLogicMD. The nation,s largest and fastest... exclusively in medically supervised bioidentical...in its network since November 2008 - from 21 to...hysician-owned centers, including one in Puerto Ri...
(Date:11/25/2009)...swire-FirstCall/ -- Ardea Biosciences, Inc. (Nasda...arm.D., president and chief executive officer, wil...Care Conference. , ,Presentation details are as f...ference,Date: Tuesday, December 1, 2009,Time:...rk Palace Hotel, New York, NY,Webcast: <a href=...
(Date:11/24/2009)... investment bank KTA Capital,s client Neuren Pharm...convertible note private placement with a U.S. ins...anged by KTA Capital as Neuren,s exclusive placeme...ew York (PRWEB) November 23, 2009 -- The independe...t;KTA Capital") has announced that its client...
Breaking Biology Technology:Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
...Drug,Delivery: Emerging Modes, Novel Science and P...for October 29-30, 2007, at the Flamingo in Las,Ve...in controlled release,technologies, nanobiomedicin...g delivery, tumor targeting and other novel applic...ther systemic drug absorption,platforms. The prog...
...e "Company") (Nasdaq: VRML ) announced today that...Stock Market ("Nasdaq") that the Company has,regai...)(3) as a result of,achieving a market value of li...35 million or more for a period of 10 consecutive ...st 17, 2007 that the Company was not in,compliance...
...SPeRATE Hypertension Treatment Device ..., Sept. 17 InterCure, Ltd. (TASE:,INCR), today an...nt device,clinically-proven in 10 peer-reviewed st...launch into retail distribution in the United King...stributor of healthcare,diagnostics to the indepen...
Other Biology Technology:Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIG's Plenary Panel in Vegas 2Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIG's Plenary Panel in Vegas 3Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq 2InterCure and Mashco Announce Launch into Independent Pharmacies in the United Kingdom 2InterCure and Mashco Announce Launch into Independent Pharmacies in the United Kingdom 3InterCure and Mashco Announce Launch into Independent Pharmacies in the United Kingdom 4
(Date:11/25/2009)...ors recently received funding from the National Sc...cial to understanding the environment. The three g...ssistant professor in the Department of Biological...ate research projects. , His first project, titl...unctions from the Leaf to the Landscape," will exa...
(Date:11/24/2009)... may help gut bacteria bind to the gastrointestina...oducers to identify strains that are likely to be ...interact with cells lining the gut to have a benef...e gut they are more likely to stick around long en...ge from the Institute of Food Research. IFR is an...
(Date:11/24/2009)...rets of the earth,s history locked in its icy dept... information on the environments that have been se...ow, a team of researchers from nine institutions ... million dollars by the National Science Foundatio...ly. These scientists will drill through the West A...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2A sticky solution for identifying effective probiotics 2LSU gets to the bottom of things -- in Antarctica 2GENova Biotherapeutics signs collaboration agreement with Prime BioResearch 57276 1GENova Biotherapeutics signs collaboration agreement with Prime BioResearch 57276 2GENova Biotherapeutics signs collaboration agreement with Prime BioResearch 57276 3FDA Approves Vaccines for 2009 H1N1 Influenza Virus 57274 1FDA Approves Vaccines for 2009 H1N1 Influenza Virus 57274 2FDA Approves Vaccines for 2009 H1N1 Influenza Virus 57274 3Diabetes Medications Dont Lower Inflammation 57271 1Diabetes Medications Dont Lower Inflammation 57271 2Diabetes Medications Dont Lower Inflammation 57271 3
...sociation for Cancer Research extends its sincere ...nomination to lead the Food and Drug Administratio...see the advancement of cutting-edge products and t...vention of cancer. Her leadership will bring new p...devising regulatory pathways for biomarker approva...
...roviral therapy) has emerged as an extremely effec...undetectable; however, HAART can never truly eradi...in cells. But, a chemical called suberoylanilide h...emia drug, has now been shown to ,turn on, latent ... the hidden virus that HAART misses. , Matija Pe...
...ygen atoms dancing on a metal oxide slab, glowing ...ts better understand how water splits into oxygen ...visualized a chemical reaction that had previously... understanding of the chemistry needed to generate... water. , The scientists made the discovery while...
Other Biology News:Dancing 'adatoms' help chemists understand how water molecules split 2Dancing 'adatoms' help chemists understand how water molecules split 3
Goat Anti-Human NP-1 (Alpha-Defensin-1) Polyclonal Antibody, Unconjugated from PeproTech
Rabbit Anti-Raf-1 (C-12)-G Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Anti-Human Amyloid beta [1-16] Monoclonal Antibody, Unconjugated, Clone 6E10 from Cell Sciences
...Development kit contains the basic components requ...sure natural and recombinant mouse Dickkopf homolo...Each kit contains sufficient materials to run ELIS...ed that the following conditions are met: The ass...
Biology Products: